Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent primary biliary cirrhosis.

J Neuberger1

  • 1Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK.

Bailliere'S Best Practice & Research. Clinical Gastroenterology
|September 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect on consent rates for deceased organ donation in Wales after the introduction of an opt-out system.

Anaesthesia·2020
Same author

Editorial: covert hepatic encephalopathy-silent but serious.

Alimentary pharmacology & therapeutics·2018
Same author

Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay.

Journal of virological methods·2017
Same author

Donors With Immune Thrombocytopenia: Do They Pose a Risk to Transplant Recipients?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.

Alimentary pharmacology & therapeutics·2016
Same author

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same journal

Preface.

Bailliere's best practice & research. Clinical gastroenterology·2001
Same journal

Liver transplantation of patients in end-stage cirrhosis.

Bailliere's best practice & research. Clinical gastroenterology·2001
Same journal

The hepatopulmonary syndrome.

Bailliere's best practice & research. Clinical gastroenterology·2001
Same journal

Splenomegaly, hypersplenism and coagulation abnormalities in liver disease.

Bailliere's best practice & research. Clinical gastroenterology·2001
Same journal

Early diagnosis and treatment of hepatocellular carcinoma.

Bailliere's best practice & research. Clinical gastroenterology·2001
Same journal

Diagnosis, treatment and prevention of spontaneous bacterial peritonitis.

Bailliere's best practice & research. Clinical gastroenterology·2001
See all related articles

Recurrence of primary biliary cholangitis (PBC) after liver transplant is common, affecting 30-50% of patients within 10 years. While histological evidence can be variable, PBC autoantibodies often persist, impacting long-term graft health.

Area of Science:

  • Hepatology
  • Transplant Immunology
  • Autoimmune Liver Disease

Background:

  • Liver transplantation is a standard treatment for end-stage liver disease.
  • Diagnosing recurrent primary biliary cholangitis (PBC) in liver allografts presents challenges.
  • Conventional PBC diagnostic criteria may not apply to the post-transplant setting.

Purpose of the Study:

  • To review the diagnostic challenges and clinical implications of recurrent PBC in liver allografts.
  • To assess the prevalence and histological features of PBC recurrence.
  • To identify factors influencing PBC recurrence and its impact on graft outcomes.

Main Methods:

  • Review of existing literature on PBC recurrence post-liver transplantation.
  • Analysis of diagnostic criteria, histological findings, and serological markers (e.g., AMA, gp-210).

Related Experiment Videos

  • Evaluation of clinical impact and potential management strategies.

    • Main Results:

    • PBC-specific autoantibodies (AMA, gp-210) consistently persist post-transplant.
    • Histological features of PBC, including granulomatous damage and ductopenia, are observed in allografts.
    • Recurrence rates increase over time, reaching 30-50% by 10 years.
    • No clear risk factors for recurrence identified, though immunosuppression may play a role.
    • Recurrence generally has minimal medium-term clinical impact; cirrhosis is rare.

    Conclusions:

    • Diagnosing recurrent PBC in liver allografts requires careful consideration of specific autoantibodies and histological findings.
    • While recurrence is frequent, its clinical significance in the medium term appears limited.
    • Further research is needed to clarify risk factors and optimize management, including the role of ursodeoxycholic acid.